Correlation Between Mobivity Holdings and Integrated Biopharma
Can any of the company-specific risk be diversified away by investing in both Mobivity Holdings and Integrated Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mobivity Holdings and Integrated Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mobivity Holdings and Integrated Biopharma, you can compare the effects of market volatilities on Mobivity Holdings and Integrated Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mobivity Holdings with a short position of Integrated Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mobivity Holdings and Integrated Biopharma.
Diversification Opportunities for Mobivity Holdings and Integrated Biopharma
0.13 | Correlation Coefficient |
Average diversification
The 3 months correlation between Mobivity and Integrated is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Mobivity Holdings and Integrated Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Integrated Biopharma and Mobivity Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mobivity Holdings are associated (or correlated) with Integrated Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Integrated Biopharma has no effect on the direction of Mobivity Holdings i.e., Mobivity Holdings and Integrated Biopharma go up and down completely randomly.
Pair Corralation between Mobivity Holdings and Integrated Biopharma
Given the investment horizon of 90 days Mobivity Holdings is expected to generate 5.44 times more return on investment than Integrated Biopharma. However, Mobivity Holdings is 5.44 times more volatile than Integrated Biopharma. It trades about 0.03 of its potential returns per unit of risk. Integrated Biopharma is currently generating about -0.18 per unit of risk. If you would invest 98.00 in Mobivity Holdings on August 31, 2024 and sell it today you would lose (71.00) from holding Mobivity Holdings or give up 72.45% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 8.31% |
| Values | Daily Returns |
Mobivity Holdings vs. Integrated Biopharma
Performance |
| Timeline |
| Mobivity Holdings |
| Integrated Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Mobivity Holdings and Integrated Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mobivity Holdings and Integrated Biopharma
The main advantage of trading using opposite Mobivity Holdings and Integrated Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mobivity Holdings position performs unexpectedly, Integrated Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Integrated Biopharma will offset losses from the drop in Integrated Biopharma's long position.| Mobivity Holdings vs. HUMANA INC | Mobivity Holdings vs. Aquagold International | Mobivity Holdings vs. Barloworld Ltd ADR | Mobivity Holdings vs. Thrivent High Yield |
| Integrated Biopharma vs. Premier Foods Plc | Integrated Biopharma vs. Torque Lifestyle Brands | Integrated Biopharma vs. Naturally Splendid Enterprises | Integrated Biopharma vs. Aryzta AG PK |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Complementary Tools
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |